Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Adagene

3.75
-0.0400-1.06%
Post-market: 3.68-0.0700-1.87%17:54 EDT
Volume:69.40K
Turnover:264.25K
Market Cap:247.77M
PE:-10
High:3.95
Open:3.44
Low:3.40
Close:3.79
52wk High:4.75
52wk Low:1.30
Shares:66.07M
Float Shares:43.11M
Volume Ratio:0.91
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3750
EPS(LYR):-0.3750
ROE:-34.39%
ROA:-16.00%
PB:7.01
PE(LYR):-10.00

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
Adagene
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
128
Office Location:
Building C14,4th Floor,No. 218, Xinghu Street,Suzhou Industrial Park,Suzhou,Jiangsu Province,China
Website:
- -
Zip Code:
215123
Phone:
86 512 8777 3632
Fax:
- -
Introduction:
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Their platform is designed to generate therapeutic antibody candidates with unique functional epitopes and species cross-reactivity. These features enable their novel drug discovery strategy to advance from lead identification through vigorous preclinical modeling to biomarker-guided mono- and combination immunotherapy development in clinical settings. They have pioneered a dynamic interface design to harness the conformational diversity of antibodies, which enlarges epitope sampling of a given drug target for differentiated therapeutic antibody development. Their platform is designed to enable the rapid development of precision immunotherapy candidates, through the identification of predictive biomarkers for patient stratification and preselection.

Directors

Name
Position
Peter Luo
Chairman of the Board and Chief Executive Officer and President of R&D
Andy Cheung
Independent Director
Cuong Do
Independent Director
Li Zhu
Independent Director
Man Kin Tam
Chief Financial Officer and Director
Ulf Grawunder
Independent Director

Shareholders

Name
Position
Peter Luo
Chairman of the Board and Chief Executive Officer and President of R&D
Guizhong Liu
Senior Vice President of Early Drug Discovery
Man Kin Tam
Chief Financial Officer and Director
Songmao Zheng
Senior Vice President of Clinical Pharmacology and Quantitative Sciences
Xiaohong She
Head of Clinical Operations and Senior Vice President
Yan Li
Senior Vice President, Bioinformatics and Information Technology
Alexander Goergen
Head of Business Development and Vice President
Chunfang Gu
Executive Director of Finance
Jiping Zha
Executive Vice President of Clinical Development
Ling Zhou
Executive Director of Human Resources
Mickael Chane Du
Chief Strategy Officer
Qinghai Zhao
Chief Manufacturing Officer
Wenlin Zeng
Vice President of Early Stage CMC